Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene

Mol Cell Biol. 1987 May;7(5):2019-23. doi: 10.1128/mcb.7.5.2019-2023.1987.

Abstract

We investigated alterations in the structure and expression of oncogenes in mammary tumors and mammary tumor-derived cell lines. In 16 of 95 samples, we detected amplification of the human neu oncogene, also known as c-erB-2, accompanied by overexpression in the tumors from which intact RNA could be isolated. In 10 of these DNAs, the linked oncogene c-erbA was also amplified, whereas another gene on human chromosome 17, p53, was present in normal copy numbers. Overexpression of c-erbA could not be detected in the tumors analyzed. The relatively high frequency of neu amplification points to a functional role in human breast cancer. Coamplification of the c-erbA oncogene could contribute to this disease as well but is most likely fortuitous.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / pathology
  • Cell Line
  • Chromosomes, Human, Pair 17*
  • Gene Amplification*
  • Genetic Linkage
  • Humans
  • Lymphatic Metastasis
  • Neoplasm Proteins / genetics
  • Oncogenes*
  • Phosphoproteins / genetics
  • Proto-Oncogene Proteins / genetics*
  • Receptors, Estrogen / analysis
  • Thyroglobulin / genetics
  • Tumor Suppressor Protein p53

Substances

  • Neoplasm Proteins
  • Phosphoproteins
  • Proto-Oncogene Proteins
  • Receptors, Estrogen
  • Tumor Suppressor Protein p53
  • Thyroglobulin